Health Highlights: April 3, 201204/03/12
Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Education Level Affects Longevity: Study
Americans are living longer overall, but better educated people
are increasingly the main beneficiaries of gains in life span,
according to a new study.
University of Wisconsin researchers analyzed data from more than
3,000 counties across the United States and found that rates of
premature death (before age 75) differed sharply across counties,
and that a lack of college education accounted for about 35 percent
of that variation from 2006 to 2008,
The New York Times reported.
That was an increase from 30 percent over an equivalent period
seven years earlier.
The study also found that an average increase of one year in
post-secondary education levels was associated with a 16 percent
decrease in years of life lost before age 75, the
Cheney Goes Home 10 Days After Heart Transplant
Ten days after undergoing a heart transplant, former U.S. Vice
President Dick Cheney has returned to his Virginia home.
After a wait of nearly two years, the 71-year-old Cheney
received a new heart on March 24. Since the age of 37, Cheney has
had five heart attacks. The most recent was in 2010,
USA Today reported.
"As he leaves the hospital, the former vice president and his family want to again express their deep gratitude to the donor and the donor's family for this remarkable gift," said a statement from Cheney's office.
The statement also thanked doctors at Inova Fairfax and George
Washington University hospitals, and the intensive-care nursing
staff at the Inova Fairfax Heart and Vascular Institute,
USA Today reported.
Mutant Bird Flu Virus Less Deadly Than Feared: Scientist
The author of a paper on a mutant strain of H5N1 bird flu said
experts agreed to allow publication of the paper after he explained
that the mutant virus was much less deadly than previously
In a reversal of an earlier decision to withhold key details,
U.S. science and security officials decided Friday to allow
publication of two papers on mutant H5N1 viruses. There were
concerns that the papers' findings could be used by bioterrorists,
Agence France-Presse reported.
The author of one of the papers told journalists that the
revised version of his paper addressed those fears and made it
clear that the mutant virus is "much less lethal" than initially
"I did say that it's one of the most dangerous viruses, and it's the truth, because these viruses are a little scary," said Professor Ron Fouchier, of the Erasmus Medical Center in the Netherlands, AFP reported. "If they go airborne they can cause pandemics
and pandemic flu has killed millions of people."
New COPD Drug Effective: Novartis
An experimental drug for the lung condition chronic obstructive
pulmonary disorder proved successful in late-stage clinical trials,
according to pharmaceutical company Novartis AG.
The drug, called QVA149, is a combination of two other Novartis
drugs, the Arcapta Neohaler and the Seebri Breezhaler,
Bloomberg News reported.
The three clinical trials found that the combination drug
improved lung function more than either of the individual drugs,
and that patients who took QVA149 were able to exercise longer than
those who took a placebo.
The three studies are among 10 that Novartis plans to use when
it applies for regulatory approval of QVA149 in Europe and Japan,
Copyright © 2012
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.